120 related articles for article (PubMed ID: 8403196)
1. Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.
Peleg R; Romzova M; Kogan-Zviagin I; Apte RN; Priel E
BMC Cancer; 2014 Dec; 14():910. PubMed ID: 25472619
[TBL] [Abstract][Full Text] [Related]
2. Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.
Maede Y; Shimizu H; Fukushima T; Kogame T; Nakamura T; Miki T; Takeda S; Pommier Y; Murai J
Mol Cancer Ther; 2014 Jan; 13(1):214-20. PubMed ID: 24130054
[TBL] [Abstract][Full Text] [Related]
3. STK295900, a dual inhibitor of topoisomerase 1 and 2, induces G(2) arrest in the absence of DNA damage.
Kim SO; Sakchaisri K; Thimmegowda NR; Soung NK; Jang JH; Kim YS; Lee KS; Kwon YT; Asami Y; Ahn JS; Erikson RL; Kim BY
PLoS One; 2013; 8(1):e53908. PubMed ID: 23349762
[TBL] [Abstract][Full Text] [Related]
4. The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2.
Marzi L; Sun Y; Huang SN; James A; Difilippantonio S; Pommier Y
Mol Cancer Ther; 2020 Aug; 19(8):1589-1597. PubMed ID: 32430490
[TBL] [Abstract][Full Text] [Related]
5. The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage.
Gatto B; Richter S; Moro S; Capranico G; Palumbo M
Nucleic Acids Res; 2001 Oct; 29(20):4224-30. PubMed ID: 11600711
[TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerases: Advances in understanding of cellular roles and multi-protein complexes via structure-function analysis.
McKie SJ; Neuman KC; Maxwell A
Bioessays; 2021 Apr; 43(4):e2000286. PubMed ID: 33480441
[TBL] [Abstract][Full Text] [Related]
7. Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases.
Jain CK; Majumder HK; Roychoudhury S
Curr Genomics; 2017 Feb; 18(1):75-92. PubMed ID: 28503091
[TBL] [Abstract][Full Text] [Related]
8. Repair of topoisomerase I-mediated DNA damage.
Pommier Y; Barcelo JM; Rao VA; Sordet O; Jobson AG; Thibaut L; Miao ZH; Seiler JA; Zhang H; Marchand C; Agama K; Nitiss JL; Redon C
Prog Nucleic Acid Res Mol Biol; 2006; 81():179-229. PubMed ID: 16891172
[TBL] [Abstract][Full Text] [Related]
9. Type IA Topoisomerases as Targets for Infectious Disease Treatments.
Seddek A; Annamalai T; Tse-Dinh YC
Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33401386
[TBL] [Abstract][Full Text] [Related]
10. Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II.
Molinaro C; Martoriati A; Pelinski L; Cailliau K
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33027952
[TBL] [Abstract][Full Text] [Related]
11. Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.
Baikar S; Malpathak N
Pharmacogn Rev; 2010 Jan; 4(7):12-26. PubMed ID: 22228937
[TBL] [Abstract][Full Text] [Related]
12. Reduced sensitivity to camptothecin of topoisomerase I from a L5178Y mouse lymphoma subline sensitive to X-radiation.
Kowalska-Loth B; Staron K; Buraczewska I; Szumiel I; Kapiszewska M; Lange CS
Biochim Biophys Acta; 1993 Feb; 1172(1-2):117-23. PubMed ID: 8382526
[TBL] [Abstract][Full Text] [Related]
13. The sensitivity to camptothecin of DNA topoisomerase I in L5178Y-S lymphoma cells.
Staron K; Kowalska-Loth B; Szumiel I
Carcinogenesis; 1994 Dec; 15(12):2953-5. PubMed ID: 8001262
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
Beck WT; Danks MK
Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118
[TBL] [Abstract][Full Text] [Related]
15. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
16. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
[TBL] [Abstract][Full Text] [Related]
17. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.
Evans HH; Ricanati M; Horng MF; Mencl J
Mutat Res; 1989 Jan; 217(1):53-63. PubMed ID: 2536134
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
